Pharmaceutical major Dr Reddy’s Laboratories reported a 6.36 per cent YoY profit growth in the second quarter of FY2025-26. The pharma company posted a consolidated net profit of Rs 1,426 crore in Q2 FY26. In the same quarter of the previous fiscal year, the company’s consolidated net profit was Rs 1,341 crore. Further, Dr Reddy’s reported 8.9 per cent YoY revenue growth in the quarter. The company’s consolidated revenue from operations in Q2 FY26 stood at Rs 8,805 crore, compared to Rs 8,016 crore in Q2 FY25.